Physical training normalizes nucleotide hydrolysis and biochemical parameters in blood serum from streptozotocin-diabetic rats

Archives of Physiology and Biochemistry

Volumn 118, Issue 5, 2012, Pages 253-259

  Moritz, César Eduardo Jacintho ^a   Abreu Vieira, Gustavo ^a   Piroli, Camila ^a   De Senna, Priscylla Nunes ^a,c   Cardoso, Valesca Veiga ^a   Wink, Márcia Rosangela ^b,c   Harthmann, Ângela D'Avila ^a   Rücker, Bárbara ^b   Casali, Emerson André ^a,b  

^a Centro Universitário Metodista Do IPA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Diabetes; E NPPs; E NTPDases; Ecto 5 nucleotidase CD73; Physical training

Indexed keywords

BIOLOGICAL MARKER; NUCLEOTIDE;

ANIMAL; ANIMAL EXPERIMENT; ARTICLE; BLOOD; BODY WEIGHT; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HYDROLYSIS; MALE; METABOLISM; RAT; WISTAR RAT;

ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; HYDROLYSIS; MALE; NUCLEOTIDES; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, WISTAR;

RATTUS;

EID: 84869429378     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2012.697173     Document Type: Article

References (52)

1. Ataman OV. (1991). Ectonucleotidase activity of isolated strips of arteries and veins of experimental animals. Infuence of various damaging agents on ecto-ATPase activity of blood vessels. Fiziol Zh 37:32-7.
2. Autenrieth C, Schneider A, Döring A, Meisinger C, Herder C, Koenig W, Huber G, Torand B. (2009). Association between diferent domains of physical activity and markers of infammation. Med Sci Sports Exerc 41(9):1706-13.
3. Bitzur R, Cohen H, Kamari Y, Shaish A, Harats D. (2009). Triglycerides and HDL cholesterol: stars or second leads in diabetes? Diabetes Care 32:S373-7.
4. Bradford MM. (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-54.
5. Brownlee M. (2005). Te pathobiology of diabetic domplications. Diabetes 54:1615-25.
6. Canani LH, Ng DPK, Smiles A, Rogus JJ, Warram JH, Krolewski A. (2002). Polymorphism in ecto-nucleotide pyrophosphatase/phosphodiesterase 1 Gene (ENPP1/PC-1) and early development of advanced diabetic nephropathy in type 1 Diabetes. Diabetes 51:1188-93.
7. Chan K, Delfert D, Junger KD. (1986). A direct colorimetric assay for CaATPase activity. Anal Biochem 157(2):375-80.
8. Coppola A, Coppola L, dalla Mora L, Limongelli FM, Grassia A, Mastrolorenzo L, Gombos G, Lucivero G. (2005). Vigorous exercise acutely changes platelet and B-lymphocyte CD39 expression. J Appl Physiol 98(4):1414-19.
9. Duarte JM, Oses JP, Rodrigues RJ, Cunha RA. (2007). Modifications of purinergic signaling in the hippocampus of streptozotocin-induced diabetic rats. Neuroscience 149:382-91.
10. Duarte MFD, Loro VL, Rocha JBT, Leal DBR, de Bem AF, Dorneles A, Morsch VM, Schetinger MRC. (2007). Enzymes that hydrolyze adenine nucleotides of patients with hypercholesterolemia and infammatory processes. FEBS Journal 274:2707-14.
11. Di Paola R, Caporarello N, Marucci A, Dimatteo C, Ladicicco C, Del Guerra S, Prudente S, Sudando D, Miele C, Parrino C, et al. (2011). ENPP1 afects insulin action and secretion:evidences from in vitro studies. Plos One 6(5):e19462.
12. Enjyoji K, Sévigny J, Lin Y, Frenette PS, Christie PD, Esch II JSA, Imai M, Edelberg JM, Rayburn H, Lech M, et al. (1999). Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nature Med 5:1010-17.
13. Frassetto SS, Dias RD, Sarkis JJ. (1993). Characterization of an ATP diphosphohydrolase activity (APYRASE, EC 3.6.1.5) in rat blood platelets. Mol Cell Biochem 129(1):47-55.
14. Fürstenau CR, Trentin DS, Gossenheimer AN, Ramos DB, Casali EA, Barreto-Chaves ML, Sarkis JJF. (2008). Ectonucleotidase activities are altered in serum and platelets of l-NAME-treated rats. Blood Cells Mol Dis 41:223-9.
15. Goodyear LJ, Kahn BB. (1998). Exercise, glucose transport, and insulin sensitivity. Annual Review Medicine 49:235-261.
16. Grinthal A, Guidotti G. (2006). CD39, NTPDase 1, is attached to the plasma membrane by two transmembrane domains. Why? Purinergic Signal 2(2):391-8.
17. Grobben B, Anciaux K, Roymans D, Stefan C, Bollen M, Esmans EL, Slegers H. (1999). An ecto-nucleotide pyrophosphatase is one of the main enzymes involved in the extracellular metabolism of ATP in rat C6 glioma. J Neurochem 72:826-34.
18. Harthmann AD, De Angelis K, Costa LP, Senador D, Schaan BD, Krieger EM, Irigoyen MC. (2007). Exercise training improves arterial baro-and chemorefex in control and diabetic rats. Auton Neurosci 133(2):115-20.
19. Hu G, Sarti C, Jousilahti P, Silventoinen K, Barengo NC, Tuomilehto J. (2005). Leisure time, occupational, and commuting physical activity and the risk of stroke. Stroke 36(9):1994-9.
20. Ivy JL. (1997). Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-depedent diabetes mellitus. Sports Med 24(5):321-36.
21. Kreisberg RA. (1998). Diabetic dyslipidemia. Am J Cardiol, 17;82(12A):67U-73U; 85U-86U.
22. Koziak K, Kaczmarek E, Kittel A, Sévigny J, Blusztajn JK, Schulte Am Esch J 2nd, Imai M, Guckelberger O, Goepfert C, Qawi I, et al. (2000). Palmitoylation targets CD39/endothelial ATP diphosphohydrolase to caveolae. J Biol Chem 275:2057-62.
23. Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, et al. (2002). Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 55:65-85.
24. Laaksonen DE, Atalay M, Niskanen LK, Mustonen J, Sen CK, Lakka TA, Uusitupa MI. (2000). Aerobic exercise and the lipid profile in type 1 diabetic men: a randomized controlled trial. Med Sci Sports Exerc 32(9):1541-8.
25. Liu I-M, Chang CK, Juang S-W, Kou DH, Tong YC, Cheng KC, Cheng JT. (2008). Role of hyperglycaemia in the pathogenesis of hypertension observed in type-1 diabetic rats. Int J Exp Path 89:292-300.
26. Lunkes GI, Lunkes D, Stefanello F, Morsch A, Morsch VM, Mazzanti CM, Schetinger MRS. (2003). Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. Tromb Res 15;109(4):189-94.
27. Lunkes GI, Lunkes DS, Leal D, Araujo Mdo C, Correa M, Becker L, Rosa CS, Morsch VM, Schetinger MR. (2008). Efect of high glucose levels in human platelet NTPDase and 5′-nucleotidase activities. Diabetes Res Clin Pract 81:351-7.
28. Maddux BA, Goldfine ID. (2000). Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. Diabetes 49(1):13-9.
29. Oses JP, Cardoso CM, Germano RA, Kirst IB, Rücker B, Fürstenau CR, Wink MR, Bonan CD, Battastini AM, Sarkis JJ. (2004). Soluble NTPDase:An additional system of nucleotide hydrolysis in rat blood serum. Life Sci 74(26):3275-84.
30. Papanikolaou A, Papafotika A, Murphy C, Papamarcaki T, Tsolas O, Drab M, Kurzchalia T V, Kasper M, Christoforidis S. (2005). Cholesterol-dependent lipid assemblies regulate the activity of the ecto-nucleotidase CD39. J Biol Chem 280:26406-14.
31. Ralevic V, Burnstock G. (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50(3):413-92.
32. Reutershan J, Vollmer I, Stark S, Wagner R, Ngamsri K, Eltzschig HK. (2009). Adenosine and infammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafcking into the lungs. FASEB J 23(2):473-82.
33. Ribeiro SML, Rogero MM, Bacurau RFP, Campos PL, Luz SS, Lancha AH, Tirapegui J. (2010). Efects of diferent levels of protein intake and physical training on growth and nutritional status of young rats. J Nutr Sci Vitaminol 56:177-84.
34. Robson SC, Daoud S, Bégin M, Côté YP, Siegel JB, Bach FH, Beaudoin AR. (1997). Modulation of vascular ATP diphosphohydrolase by fatty acids. Blood Coagul Fibrinolysis 8(1):21-7.
35. Robson SC, Sévigny J, Zimmermann H. (2005). Te E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal 2:409-430.
36. Rücker B, Almeida ME, Libermann TA, Zerbini LF, Wink MR, Sarkis JJ. (2008). E-NTPDases and ecto-5′-nucleotidase expression profile in rat heart left ventricle and the extracellular nucleotide hydrolysis by their nerve terminal endings. Life Sci 82(9-10):477-86.
37. Rücker B, Vieira GA, Bischof LB, Harthmann AD, Sarkis JJF, Wink MR, Casali EA. (2010). Te nucleotide hydrolysis is altered in blood serum ofstreptozotocin-induced diabetic rats. Arch Physiol Biochem 116(2):79-87.
38. Sakura H, Nagashima S, Nakashima A, Maeda M. (1998). Characterization of fetal serum 5′-nucleotide phosphodiesterase: a novel function as a platelet aggregation inhibitor in fetal circulation. Tromb Res 91:83-9.
39. Siqueira IR, Elsner VR, Rilho LS, Bahlis MG, Bertoldi K, Rozisky JR, Batasttini AMO, Torres ILT. (2010). A neuroprotective exercise protocol reduces the adenine nucleotide hydrolysis in hippocampal synaptosomes and serum of rats. Brain Res 1316:173-80.
40. Sortica DA, Crispim D, Zafari G P, Friedeman R, Canani LH. (2011). Te role of ecto-nucleotide pyrophosphatase/phosphodiesterase 1 in diabetic nephropathy. Arq Bras Endocrinol Metab 55(9):677-85.
41. Soslau G, Youngprapakorn D. (1997). A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation. Biochim Biophys Acta 1355(2):131-40.
42. Souza MS, Machado UF, Okamoto M, Bertoluci MC, Ponpermeyer C, Leguisamo N, Azambuja F, Irigoyen MC, Schaan BD. (2008). Reduced cortical renal GLUT1 expression induced by angiotensin-converting enzyme inhibition in diabetic spontaneously hypertensive rats. Braz J Med Biol Res 41(11):960-8.
43. Spanevello RM, Mazzanti CM, Bagatini M, Correa M, Schmatz R, Stefanello N, Tomé G, Morsch VM, Becker L, Bellé L, et al. (2009). Activities of the enzymes that hydrolyze adenine nucleotides in platelets from multiple sclerosis patients. J Neurol 257:24-30.
44. Stefan C, Jansen S, Bollen M. (2005). NPP-type ectophospho-diesterases: unity in diversity. Trends Biochem Sci 30:542-50.
45. Stefan C, Jansen S, Bollen M. (2006). Modulation of purinergic signaling by NPP-type ectophosphodiesterases. Purinergic Signal 2:361-70.
46. Todorov LD, Mihaylova-Todorova S, Westfall TD, Sneddon P, Kennedy C, Bjur RA, Westfall DP. (1997). Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature 387(6628):76-9.
47. Trigona B, Aggoun Y, Maggio A, Martin XE, Marchand LM, Beghetti M, Farpour-Lambert NJ. (2010). Preclinical noninvasive markers of atherosclerosis in children and adolescents with type 1 diabetes are infuenced by physical activity. J Pediatr 157(4):533-9.
48. Vuaden FC, Cognato GP, Bonorino C, Bogo MR, Sarkis JJF, Bonan CD. (2007). Lipopolysaccharide alters nucleotidase activities from lymphocytes and serum of rats. Life Sci 80(19):1784-91.
49. Yegutkin GG. (1997). Kinetic analysis of enzymatic hydrolysis of ATP in human and rat blood serum. Biochem 62(6):619-22.
50. Yegutkin GG, Samburski SS, Mortensen SP, Jalkanen S, González- Alonso J. (2007). Intravascular ADP and soluble nucleotidases contribute to acute prothrombotic state during vigorous exercise in humans. J Physiol, 579(Pt 2):553-64.
51. Yegutkin GG. (2008). Nucleotide and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochim Biophys Acta 1783:673-94.
52. Zimmermann H, Braun N. (1996). Extracellular metabolism of nucleotides in the nervous system. J Auton Pharmacol 16(6):397-400.